OUTbio Board Members
Board Members & Officers
DARREN H. WONG (he, him, his)
President, Board Member
Darren is the President and a Board Member of OUTbio: Greater New York and currently resides in Manhattan with his husband. Having been involved in OUTbio during his time in Boston, he was interested in developing a similar community of LGBTQ+ biotech professionals in the New York area.
A San Francisco native, Darren received his bachelor’s degree from UC Berkeley, his PhD from UC San Francisco and completed his post-doctoral fellowship at the Dana Farber Cancer Institute/Harvard Medical School in Boston. He is currently Senior Vice President at Exarta Therapeutics where he leads a team to discover and develop novel therapeutics to treat human diseases.
RHOMEYN LEWIS (he, him, his)
Treasurer, Board Member
Rhomeyn Lewis is the the Treasurer and Board Member of OUTbio: Greater New York. He has a deep passion for fostering equitable and inclusive environments for all. With a deep love for DEI, Rhomeyn started at Meta, where he co-managed the Pride@BayArea employee resource group. He continued channeling his energy and expertise in DEI at Bridgebio, co-building the DEI program.
Rhomeyn's commitment to DEI is grounded in a solid academic background, including an MBA and BA from the University of Phoenix. In addition to a DEI certificate program at Cornell University. In all his endeavors, he strives to empower individuals and organizations to create more welcoming and supportive environments.
Rhomeyn and his husband call Manhattan home, and when he's not busy championing DEI, he indulges his passion for international travel by exploring new places and cultures.
HEATH INGRAM (he, him, his)
Secretary, Board Member
Heath Ingram is an attorney at Goodwin Procter LLP and represents life sciences and healthcare companies, including biotechnology companies, pharmaceutical and medical device manufacturers, and digital health companies at all stages of development, as well as, venture capital and private equity firms focused on all aspects of the healthcare industry. Heath is based in Manhattan and is a member of Goodwin’s Life Sciences group and Healthcare practice.
Heath serves as the Secretary and as a Board Member of OUTbio: Greater New York. Heath focuses his legal practice on corporate, regulatory, transactional, compliance, enforcement, investigations, and government advocacy matters for life science companies. Heath also serves as a lead outside counsel to The Trevor Project, the world’s largest suicide prevention and crisis intervention organization for LGBTQ young people.
A Midwest native, Heath received his JD from the Northwestern University School of Law while simultaneously earning his MA in Medical Humanities and Bioethics from Northwestern, where he focused his graduate thesis on precision medicine, genetics, and the law.
JOHN L'ECUYER (he, him, his)
John started his career in life sciences consulting 20 years ago with SmartAnalyst, where he led Global Business Development, and is now with Putnam Associates, as an Executive Director focused on Portfolio, Licensing and Development Strategy. Across the biopharma industry, he helps clients build clinical development, go-to-market and commercialization strategies for their novel pipeline therapies. He holds a degree from Columbia University. As a passionate advocate for LGBTQ+ equality – especially in the workplace, where everyone should feel empowered to bring their full selves to work – he is proud to be a part of OUTbio: Greater New York. He and his husband live in Manhattan.
JOHN NORDBERG (he, him, his)
John Nordberg has been working in pharmaceutical, biotechnology, and medical device Quality for 25 years. His career spans roles with large pharmaceutical companies including Pfizer and Novartis, in addition to small development biotech. He is currently a Senior Director at Syndax Pharmaceuticals, a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. John is based in Manhattan and serves as a Board Member of OUTbio: Greater New York.
John focuses on ensuring all aspects of investigational and commercial drug products meet regulatory and health authority quality requirements. He works closely with Regulatory Affairs, CMC, Medical Affairs, and Commercial organizations.
John received his MPH from the Boston University School of Public Health with
concentrations in Epidemiology and Biostatistics and Health Policy & Law. While at BUSPH, John served as Public Health Fellow for the Massachusetts Legislature Joint Committee on Public Health.
BRIAN THOMAS (he, him, his)
Brian Thomas is a Member of the Board for OUTbio: Greater New York.
Brian has over 20 years of experience as a molecular and cell biologist spanning academia, biotech, and pharma and has been responsible for the design, outfit, and operational oversight of several labs. Brian is currently Executive Director of Laboratory Operations for the Alexandria LaunchLabs biotech incubator located on Columbia University’s Medical School
Brian is a Utah and Wyoming native and holds a B.S. in Microbiology and a M.S. in Molecular Biology from the University of Wyoming.
Advisory Board Members
TYLER ABRAMS (he, him, his)
Advisory Board Member
Tyler is part of the Advisory Board for OUTbio: Greater New York. He is from Phoenix, AZ and moved to Brooklyn shortly after graduating from Arizona State University with a BA in Communication and a minor in Women and Gender Studies.
At the height of the pandemic, Tyler began his career in Life Sciences recruitment and has collaborated with various pharmaceutical and biotechnology companies throughout the United States for their niche
hiring needs. After connecting with a few members from OUTbio in Boston, he is elated to further develop his passion for relationship-building and the empowerment of the LGBTQIA* community in New York.
COLLIN SPENCER (he, him, his)
Advisory Board Member
Collin is a Ph.D. candidate in Biomedical AI at the Mount Sinai School of Medicine, where he conducts research on the molecular pathogenesis of Alzheimer's Disease to identify novel therapeutic targets. He is also a Schmidt Futures Research Fellow, developing a playbook for entrepreneurial scientists starting therapeutics companies. Outside the lab, Collin is Director of Partnerships for Nucleate NYC, a non-profit educating academic scientists on how to spin out biotech companies.
Collin’s work at OUTbio: Greater New York is motivated by his roots in LGBTQ+ and mental health advocacy. After the tragic shooting of an LGBT+ student, he spearheaded the first U.S. student-run national research consortium on college mental health policy. To translate findings, he raised and allocated a million-dollar fund for mental health infrastructure and technologies at his alma mater. He holds a bachelor’s degree in biological sciences from Georgia Tech. After his graduate studies, he aims to build biotech startups through venture creation and venture capital.